JP2008526923A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526923A5 JP2008526923A5 JP2007550789A JP2007550789A JP2008526923A5 JP 2008526923 A5 JP2008526923 A5 JP 2008526923A5 JP 2007550789 A JP2007550789 A JP 2007550789A JP 2007550789 A JP2007550789 A JP 2007550789A JP 2008526923 A5 JP2008526923 A5 JP 2008526923A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- aza
- bicyclo
- dichloro
- phenoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 208000002193 Pain Diseases 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- 208000035475 disorder Diseases 0.000 claims 6
- 125000001475 halogen functional group Chemical group 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 208000011580 syndromic disease Diseases 0.000 claims 5
- -1 trifluoromethoxy, cyano, hydroxy, amino Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 125000004043 oxo group Chemical group O=* 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 4
- 206010012289 Dementia Diseases 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 3
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 208000019906 panic disease Diseases 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- RECGUXXUXCNYKJ-UHFFFAOYSA-N 2-[3-(3,4-dichlorophenoxy)-8-azabicyclo[3.2.1]octan-8-yl]-1h-benzimidazole Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CC(N2C=3NC4=CC=CC=C4N=3)CCC2C1 RECGUXXUXCNYKJ-UHFFFAOYSA-N 0.000 claims 2
- 208000007848 Alcoholism Diseases 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 206010013654 Drug abuse Diseases 0.000 claims 2
- 208000030814 Eating disease Diseases 0.000 claims 2
- 208000010228 Erectile Dysfunction Diseases 0.000 claims 2
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 208000019022 Mood disease Diseases 0.000 claims 2
- 206010041250 Social phobia Diseases 0.000 claims 2
- 206010043269 Tension headache Diseases 0.000 claims 2
- 208000008548 Tension-Type Headache Diseases 0.000 claims 2
- 206010043903 Tobacco abuse Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 235000014632 disordered eating Nutrition 0.000 claims 2
- 201000001881 impotence Diseases 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 206010027175 memory impairment Diseases 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 208000011117 substance-related disease Diseases 0.000 claims 2
- QORRPMZKTUCFBC-UHFFFAOYSA-N 2-[3-(3,4-dichlorophenoxy)-8-azabicyclo[3.2.1]octan-8-yl]acetamide Chemical compound NC(=O)CN1C(C2)CCC1CC2OC1=CC=C(Cl)C(Cl)=C1 QORRPMZKTUCFBC-UHFFFAOYSA-N 0.000 claims 1
- GPFYPLFSTFLYAJ-UHFFFAOYSA-N 2-[3-(3,4-dichlorophenoxy)-8-azabicyclo[3.2.1]octan-8-yl]ethanethioamide Chemical compound NC(=S)CN1C(C2)CCC1CC2OC1=CC=C(Cl)C(Cl)=C1 GPFYPLFSTFLYAJ-UHFFFAOYSA-N 0.000 claims 1
- IUUGUKZBNRXANW-UHFFFAOYSA-N 2-[3-(5-chloropyridin-2-yl)oxy-8-azabicyclo[3.2.1]octan-8-yl]acetamide Chemical compound NC(=O)CN1C(C2)CCC1CC2OC1=CC=C(Cl)C=N1 IUUGUKZBNRXANW-UHFFFAOYSA-N 0.000 claims 1
- JLZXHHUKLJVDCJ-UHFFFAOYSA-N 2-[3-(6-bromopyridin-2-yl)oxy-8-azabicyclo[3.2.1]octan-8-yl]acetamide Chemical compound NC(=O)CN1C(C2)CCC1CC2OC1=CC=CC(Br)=N1 JLZXHHUKLJVDCJ-UHFFFAOYSA-N 0.000 claims 1
- DVPNHFCKUNVAAQ-UHFFFAOYSA-N 2-[3-(6-methoxynaphthalen-2-yl)oxy-8-azabicyclo[3.2.1]octan-8-yl]-1h-benzimidazole Chemical compound C1=CC=C2NC(N3C4CCC3CC(C4)OC3=CC4=CC=C(C=C4C=C3)OC)=NC2=C1 DVPNHFCKUNVAAQ-UHFFFAOYSA-N 0.000 claims 1
- MKEOKKKEJKPIEG-UHFFFAOYSA-N 2-[[3-(3,4-dichlorophenoxy)-8-azabicyclo[3.2.1]octan-8-yl]methyl]-1,3-thiazole Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CC(N2CC=3SC=CN=3)CCC2C1 MKEOKKKEJKPIEG-UHFFFAOYSA-N 0.000 claims 1
- AEYRGWQYFILCNY-UHFFFAOYSA-N 3-(3,4-dichlorophenoxy)-8-(1-phenylethyl)-8-azabicyclo[3.2.1]octane Chemical compound C=1C=CC=CC=1C(C)N1C(C2)CCC1CC2OC1=CC=C(Cl)C(Cl)=C1 AEYRGWQYFILCNY-UHFFFAOYSA-N 0.000 claims 1
- ZMANJVYWUCGTNI-UHFFFAOYSA-N 3-(3,4-dichlorophenoxy)-8-(2h-tetrazol-5-ylmethyl)-8-azabicyclo[3.2.1]octane Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CC(N2CC=3NN=NN=3)CCC2C1 ZMANJVYWUCGTNI-UHFFFAOYSA-N 0.000 claims 1
- GYOJVKWSHICVFG-UHFFFAOYSA-N 3-(3,4-dichlorophenoxy)-8-(pyridin-2-ylmethyl)-8-azabicyclo[3.2.1]octane Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CC(N2CC=3N=CC=CC=3)CCC2C1 GYOJVKWSHICVFG-UHFFFAOYSA-N 0.000 claims 1
- HVENPTHPFSVFGC-UHFFFAOYSA-N 3-(3,4-dichlorophenoxy)-8-(pyridin-3-ylmethyl)-8-azabicyclo[3.2.1]octane Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CC(N2CC=3C=NC=CC=3)CCC2C1 HVENPTHPFSVFGC-UHFFFAOYSA-N 0.000 claims 1
- OYDPATRTGHBYIK-UHFFFAOYSA-N 3-(3,4-dichlorophenoxy)-8-(pyridin-4-ylmethyl)-8-azabicyclo[3.2.1]octane Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CC(N2CC=3C=CN=CC=3)CCC2C1 OYDPATRTGHBYIK-UHFFFAOYSA-N 0.000 claims 1
- YOFAGYYNZCLDOR-UHFFFAOYSA-N 3-(3,4-dichlorophenoxy)-8-[(1-methyltetrazol-5-yl)methyl]-8-azabicyclo[3.2.1]octane Chemical compound CN1N=NN=C1CN1C2CCC1CC(OC=1C=C(Cl)C(Cl)=CC=1)C2 YOFAGYYNZCLDOR-UHFFFAOYSA-N 0.000 claims 1
- DBRGNZVXLLFEAC-UHFFFAOYSA-N 3-(3,4-dichlorophenoxy)-8-azabicyclo[3.2.1]octane-8-carbaldehyde Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CC(N2C=O)CCC2C1 DBRGNZVXLLFEAC-UHFFFAOYSA-N 0.000 claims 1
- WJHJIFBTEQNZTD-UHFFFAOYSA-N 3-(3,4-dichlorophenoxy)-n-phenyl-8-azabicyclo[3.2.1]octane-8-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CC(N2C(=O)NC=3C=CC=CC=3)CCC2C1 WJHJIFBTEQNZTD-UHFFFAOYSA-N 0.000 claims 1
- PJTFSHSAYFIVCR-UHFFFAOYSA-N 3-(5-chloropyridin-2-yl)oxy-8-(pyridin-2-ylmethyl)-8-azabicyclo[3.2.1]octane Chemical compound N1=CC(Cl)=CC=C1OC1CC(N2CC=3N=CC=CC=3)CCC2C1 PJTFSHSAYFIVCR-UHFFFAOYSA-N 0.000 claims 1
- QVLLBROIVKEGBT-UHFFFAOYSA-N 3-(5-chloropyridin-2-yl)oxy-8-(pyridin-3-ylmethyl)-8-azabicyclo[3.2.1]octane Chemical compound N1=CC(Cl)=CC=C1OC1CC(N2CC=3C=NC=CC=3)CCC2C1 QVLLBROIVKEGBT-UHFFFAOYSA-N 0.000 claims 1
- RMGIHFFIEOFEJP-UHFFFAOYSA-N 3-(5-chloropyridin-2-yl)oxy-8-azabicyclo[3.2.1]octane-8-carbaldehyde Chemical compound N1=CC(Cl)=CC=C1OC1CC(N2C=O)CCC2C1 RMGIHFFIEOFEJP-UHFFFAOYSA-N 0.000 claims 1
- DGGKXQQCVPAUEA-UHFFFAOYSA-N 8-azabicyclo[3.2.1]octane Chemical class C1CCC2CCC1N2 DGGKXQQCVPAUEA-UHFFFAOYSA-N 0.000 claims 1
- FPIQWTQOLJBVPI-UHFFFAOYSA-N 8-benzyl-3-(3,4-dichlorophenoxy)-8-azabicyclo[3.2.1]octane Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CC(N2CC=3C=CC=CC=3)CCC2C1 FPIQWTQOLJBVPI-UHFFFAOYSA-N 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 claims 1
- 208000008811 Agoraphobia Diseases 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 claims 1
- 208000000044 Amnesia Diseases 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000036640 Asperger disease Diseases 0.000 claims 1
- 201000006062 Asperger syndrome Diseases 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 206010003805 Autism Diseases 0.000 claims 1
- 208000020706 Autistic disease Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000032841 Bulimia Diseases 0.000 claims 1
- 206010006550 Bulimia nervosa Diseases 0.000 claims 1
- 206010058019 Cancer Pain Diseases 0.000 claims 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 208000022497 Cocaine-Related disease Diseases 0.000 claims 1
- 208000019743 Cranial nerve injury Diseases 0.000 claims 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
- 208000026097 Factitious disease Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 208000011688 Generalised anxiety disease Diseases 0.000 claims 1
- 206010065390 Inflammatory pain Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 208000026139 Memory disease Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 206010061296 Motor dysfunction Diseases 0.000 claims 1
- 208000000112 Myalgia Diseases 0.000 claims 1
- 208000008705 Nocturnal Myoclonus Syndrome Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 1
- 206010033664 Panic attack Diseases 0.000 claims 1
- 206010052794 Panic disorder with agoraphobia Diseases 0.000 claims 1
- 206010033668 Panic disorder without agoraphobia Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000027089 Parkinsonian disease Diseases 0.000 claims 1
- 206010034010 Parkinsonism Diseases 0.000 claims 1
- 208000012202 Pervasive developmental disease Diseases 0.000 claims 1
- 208000004983 Phantom Limb Diseases 0.000 claims 1
- 206010056238 Phantom pain Diseases 0.000 claims 1
- 206010034912 Phobia Diseases 0.000 claims 1
- 206010070606 Post stroke depression Diseases 0.000 claims 1
- 208000008348 Post-Concussion Syndrome Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 208000027030 Premenstrual dysphoric disease Diseases 0.000 claims 1
- 206010036618 Premenstrual syndrome Diseases 0.000 claims 1
- 206010052276 Pseudodementia Diseases 0.000 claims 1
- 208000005793 Restless legs syndrome Diseases 0.000 claims 1
- 208000006289 Rett Syndrome Diseases 0.000 claims 1
- 208000036353 Rett disease Diseases 0.000 claims 1
- 206010039966 Senile dementia Diseases 0.000 claims 1
- 206010066218 Stress Urinary Incontinence Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000011962 Substance-induced mood disease Diseases 0.000 claims 1
- 231100000395 Substance-induced mood disorder Toxicity 0.000 claims 1
- 208000000323 Tourette Syndrome Diseases 0.000 claims 1
- 208000000921 Urge Urinary Incontinence Diseases 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- 201000007930 alcohol dependence Diseases 0.000 claims 1
- 208000022531 anorexia Diseases 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 1
- 208000025748 atypical depressive disease Diseases 0.000 claims 1
- 208000029560 autism spectrum disease Diseases 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 208000028683 bipolar I disease Diseases 0.000 claims 1
- 208000022257 bipolar II disease Diseases 0.000 claims 1
- 208000029028 brain injury Diseases 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 201000001272 cocaine abuse Diseases 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 206010061428 decreased appetite Diseases 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 206010013663 drug dependence Diseases 0.000 claims 1
- 208000024732 dysthymic disease Diseases 0.000 claims 1
- MGWKDEAZUMSEPK-UHFFFAOYSA-N ethyl 2-[3-(3,4-dichlorophenoxy)-8-azabicyclo[3.2.1]octan-8-yl]acetate Chemical compound CCOC(=O)CN1C(C2)CCC1CC2OC1=CC=C(Cl)C(Cl)=C1 MGWKDEAZUMSEPK-UHFFFAOYSA-N 0.000 claims 1
- 210000001097 facial muscle Anatomy 0.000 claims 1
- 208000029364 generalized anxiety disease Diseases 0.000 claims 1
- 208000024963 hair loss Diseases 0.000 claims 1
- 230000003676 hair loss Effects 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 230000029849 luteinization Effects 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 claims 1
- 230000006984 memory degeneration Effects 0.000 claims 1
- 208000023060 memory loss Diseases 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 230000036651 mood Effects 0.000 claims 1
- 208000013465 muscle pain Diseases 0.000 claims 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 201000003631 narcolepsy Diseases 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 230000001561 neurotransmitter reuptake Effects 0.000 claims 1
- 230000000422 nocturnal effect Effects 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 208000023515 periodic limb movement disease Diseases 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 208000028173 post-traumatic stress disease Diseases 0.000 claims 1
- 206010036596 premature ejaculation Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
- 201000001716 specific phobia Diseases 0.000 claims 1
- 230000002889 sympathetic effect Effects 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
- 206010044652 trigeminal neuralgia Diseases 0.000 claims 1
- 206010046494 urge incontinence Diseases 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500068 | 2005-01-13 | ||
| US64359005P | 2005-01-14 | 2005-01-14 | |
| PCT/EP2006/050143 WO2006075004A2 (en) | 2005-01-13 | 2006-01-11 | 3, 8 - substituted 8-aza-bicyclo[3.2.1] octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526923A JP2008526923A (ja) | 2008-07-24 |
| JP2008526923A5 true JP2008526923A5 (enExample) | 2009-02-26 |
Family
ID=36096304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007550789A Abandoned JP2008526923A (ja) | 2005-01-13 | 2006-01-11 | 新規８−置換８−アザ−ビシクロ［３．２．１］オクタン誘導体及びモノアミン神経伝達物質再取り込み阻害剤としてのそれらの使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US7713990B2 (enExample) |
| EP (1) | EP1838705A2 (enExample) |
| JP (1) | JP2008526923A (enExample) |
| WO (1) | WO2006075004A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1731518B1 (en) | 2004-03-31 | 2014-06-25 | Nippon Soda Co., Ltd. | Cyclic amine compound and pest control agent |
| JP4871290B2 (ja) | 2005-10-06 | 2012-02-08 | 日本曹達株式会社 | 架橋環状アミン化合物および有害生物防除剤 |
| MX2008014672A (es) | 2006-05-19 | 2009-03-09 | Abbott Lab | Derivados de alcano azabiciclico sustituidos con bicicloheterociclo fusionado activos en el sistema nervioso central. |
| WO2009055077A1 (en) | 2007-10-25 | 2009-04-30 | Exelixis, Inc. | Tropane compounds |
| JP2011511030A (ja) * | 2008-02-05 | 2011-04-07 | ノイロサーチ アクティーゼルスカブ | ８−アザ−ビシクロ［３．２．１］オクタンの新規なフェニルエチニル誘導体及びモノアミン神経伝達物質再取り込み阻害薬としてのそれらの使用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1008645A (en) * | 1963-08-06 | 1965-11-03 | Koninklijke Pharma Fab Nv | Dibenzocycloheptane derivatives |
| US3657253A (en) * | 1970-08-31 | 1972-04-18 | Robins Co Inc A H | 3-aryloxy-8-carbamoylnortropanes |
| WO1984001151A1 (en) * | 1982-09-24 | 1984-03-29 | Beecham Group Plc | Amino-azabicycloalkyl derivatives as dopamine antagonists |
| US4916139A (en) * | 1988-03-14 | 1990-04-10 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(2,3,4,5,6-pentafluorophenoxy)-8-azabicyclo(3.2.1)octanes |
| US4861889A (en) * | 1988-03-14 | 1989-08-29 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(2,3,4,5,6-pentafluorophenoxy)-8-azabicyclo[3.2.1]octanes |
| US5272160A (en) * | 1989-05-17 | 1993-12-21 | Pfizer Inc | 2-piperidino-1-alkanol derivatives as antiischemic agents |
| WO1990014087A1 (en) * | 1989-05-17 | 1990-11-29 | Pfizer Inc. | 2-piperidino-1-alkanol derivatives as antiischemic agents |
| BR9106432A (pt) * | 1990-05-10 | 1993-05-04 | Pfizer | Indolona neuroprotetora e derivados correlatos |
| JP3036789B2 (ja) * | 1990-06-22 | 2000-04-24 | 三井化学株式会社 | 新規な複素環式化合物及び医薬組成物 |
| US5527912A (en) * | 1991-10-23 | 1996-06-18 | Pfizer Inc. | Intermediates for 2-piperidino-1-alkanol derivatives |
| US5710168A (en) * | 1991-10-23 | 1998-01-20 | Pfizer Inc. | 2-piperidino-1-alkanol derivatives as neuroprotective agents |
| US5498610A (en) * | 1992-11-06 | 1996-03-12 | Pfizer Inc. | Neuroprotective indolone and related derivatives |
| US6046213A (en) * | 1994-08-18 | 2000-04-04 | Pfizer Inc. | Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives |
| WO1996037226A2 (en) * | 1995-05-26 | 1996-11-28 | Pfizer Inc. | Combinations for the treatment of parkinsonism containing selective nmda antagonists |
| WO2003062235A1 (en) * | 2002-01-17 | 2003-07-31 | Eli Lilly And Company | Modulators of acetylcholine receptors |
| JP2005533845A (ja) | 2002-07-18 | 2005-11-10 | ファイザー・プロダクツ・インク | Ｃｃｒ１ケモカインレセプターのアンタゴニストとしての二環式ピペリジン誘導体 |
| UA82517C2 (uk) * | 2003-06-24 | 2008-04-25 | Ньюросерч А/С | Нові похідні 8-аза-біцикло[3.2.1]октану та їх застосування як інгібіторів ресорбції моноамінових медіаторів |
| EP1731518B1 (en) * | 2004-03-31 | 2014-06-25 | Nippon Soda Co., Ltd. | Cyclic amine compound and pest control agent |
-
2006
- 2006-01-11 US US11/794,365 patent/US7713990B2/en not_active Expired - Fee Related
- 2006-01-11 EP EP06703575A patent/EP1838705A2/en not_active Withdrawn
- 2006-01-11 JP JP2007550789A patent/JP2008526923A/ja not_active Abandoned
- 2006-01-11 WO PCT/EP2006/050143 patent/WO2006075004A2/en not_active Ceased
-
2010
- 2010-03-19 US US12/727,972 patent/US7989470B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008139481A (ru) | Новые 1,4-диаза-бицикло[3.2.2]нонил-оксадиазолильные производные и их медицинское применение | |
| JP2009538867A5 (enExample) | ||
| JP2010513392A5 (enExample) | ||
| RU2007106970A (ru) | Новые хромен-2-оновые производные и их применение в качестве ингибиторов обратного захвата моноаминовых нейромедиаторов | |
| CN100432075C (zh) | 作为烟碱样乙酰胆碱受体配体的二氮杂双环芳基衍生物 | |
| JP2009526816A5 (enExample) | ||
| RU2005138591A (ru) | Новые производные 8-аза-бицикло{3.2.1}октана и их применение в качестве ингибиторов обратного захвата моноаминовых нейротрансмиттеров | |
| AU2005298693A1 (en) | Novel diazabicyclic aryl derivatives and their medical use | |
| RU2008129865A (ru) | Новые производные хромен-2-она и их применение в качестве ингибиторов обратного захвата нейромедиаторов моноаминов | |
| JPWO2019183341A5 (enExample) | ||
| JP2008526923A5 (enExample) | ||
| RU2010114662A (ru) | Новые производные 1,4-диазабицикло(3.2.2)нонилпиримидина и их медицинское применение | |
| JP2010513391A5 (enExample) | ||
| JP2008524161A5 (enExample) | ||
| JP2006517567A5 (enExample) | ||
| JP2008502651A5 (enExample) | ||
| RU2010135037A (ru) | Новые производные, 1,4-диазабицикло[3.2.2]нонилоксадиазолил, полезные в качестве модуляторов никотиновых ацетилхолиновых рецепторов | |
| JP2009526023A5 (enExample) | ||
| JP2009537598A5 (enExample) | ||
| JP2006517568A5 (enExample) | ||
| JP2008502650A5 (enExample) | ||
| RU2009119919A (ru) | Новые производные хромен-2-она и их применение в качестве ингибиторов обратного захвата нейромедиаторов моноаминов | |
| JP2010501624A5 (enExample) | ||
| JP2009537600A5 (enExample) | ||
| JP2008534650A5 (enExample) |